About iCAD (DeepHealth)
iCAD develops AI-powered breast health solutions that help radiologists improve the early detection of breast cancer. Its ProFound Breast Health Suite uses deep learning to analyze mammograms, assess breast density, and identify suspicious findings. The platform is designed to increase diagnostic accuracy, reduce reading times, and optimize radiology workflows. iCAD solutions integrate with existing PACS and imaging systems and are used by hospitals, imaging centers, and breast screening programs worldwide. In 2025, iCAD was acquired by DeepHealth, a RadNet subsidiary, expanding DeepHealth's portfolio of AI-driven imaging technologies while retaining the iCAD brand.